Top access

  • Published in last 1 year
  • In last 2 years
  • In last 3 years
  • All

Please wait a minute...
  • Select all
    |
  • Review & Monography
    LIN Quan, WEN Zi-shuai, XIAO Rui, WEI Ya-nan, FU Lei, ZHANG Chen-rui, CHEN Hai-ping, HUANG Xiao-lan, YAO Chun, WU Fang-fang
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1169-1179. https://doi.org/10.16155/j.0254-1793.2025-0656
    Abrine is an alkaloid derived from plants of the genus Abrus (Fabaceae), including A. cantoniensis, A. mollis, and A. precatorius. It is one of the characteristic active ingredients of this genus and an important active ingredient of medicinal materials such as Abri Herba. Studies have used abrine as an indicator for the quality control of medicinal materials such as Abri Herba. Modern pharmacological studies have demonstrated that abrine exhibits various pharmacological activities, including anti-tumor, anti-inflammatory, anti-oxidative, and anti-depressive effects. It holds broad prospects for development and application in the prevention and treatment of malignant tumors, inflammatory diseases, liver diseases, renal ischemia-reperfusion injury, and depression-related neuropsychiatric disorders. This article reviewed the research progress in abrine regarding the extraction, detection, and analysis methods, pharmacological effects and mechanisms, and metabolism, aiming to provide reference and data support for new drug development and clinical transformation.
  • Science Dynamic
    LIAO Chang, ZUO Tian-tian, XU Feng-guo, CHEN Jia, GUO Xiao-han, LIU Jing, CHENG Xian-long, LIN Yong-qiang, AN Fu-dong
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(6): 957-968. https://doi.org/10.16155/j.0254-1793.2026-0201
    Traditional Chinese medicine (TCM) is characterized by complex actions involving multiple components, multiple targets, and holistic regulation. Conventional two-dimensional cell models and animal models have obvious limitations in simulating human physiological environments, elucidating pharmacodynamic mechanisms, and evaluating safety. Organoids and organ-on-a-chip, as emerging three-dimensional in vitro model technologies, can recapitulate human tissue structure and function in humanized and dynamic microenvironments, thereby providing a brand-new experimental platform for TCM research. This review systematically outlines the basic principles and technological advances of organoids and organ-on-a-chip, with a focus on their current applications in TCM safety evaluation, screening of active ingredients and herbal formulas, pharmacodynamic mechanism elucidation, and anti-tumor personalized therapy, and further discusses their potential roles in TCM drug development. On this basis, the major challenges currently faced by these technologies are analyzed, including insufficient model maturity, lack of standardization and verification system, as well as poor adaptability to the complex nature of TCM. Future directions integrating multi-omics and artificial intelligence are also discussed. Organoid and organ-on-a-chip technologies hold promise for promoting more systematic and precise TCM research, with significant potential in TCM drug development and quality control, thereby accelerating the modernization and internationalization of TCM.
  • Safety Monitoring
    ZHAO Qi, CHEN Rong, WANG Ya-qiong, ZHANG Ya-shuang, ZHU Meng
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1312-1319. https://doi.org/10.16155/j.0254-1793.2025-0371
    Objective: To study the heavy metals and harmful elements and the arsenic (As) speciation in Rukuaixiao preparations and evaluate the As risk. Methods: Residues of Cr, Ni, Cu, As, Cd, Hg, and Pb in 78 batches of Rukuaixiao preparations were determined by microwave digestion-inductively coupled plasma-mass spectrometry (ICP-MS). High performance liquid chromatography coupled with inductively coupled plasma-mass spectrometry (HPLC-ICP-MS) was employed to analyze six As forms. The hazard index (HI) was adopted to evaluate the risk of As in 10 batches of samples. Results: The two methods demonstrated good linear relationship, precision, repeatability, and recovery. The content of seven heavy metals varied greatly among the samples from different manufacturers. The As speciation and valence states in 10 batches of samples from E company were analyzed. The results showed that total As content was high. HPLC-ICP-MS results showed that trivalent and pentavalent As exhibited high toxicity. The HI<1 indicated that the As risk was controllable. Conclusion: The established method for the determination of seven heavy metals and harmful elements and six forms of As demonstrates high efficiency, rapidity, accuracy, and stability. This study provides data support for the formulation of the limit standards for the heavy metals and harmful elements in Rukuaixiao preparations.
  • Bioassay
    LIU Qing, LI Sha-sha, YAO Lin, CHANG Rui-heng, ZHANG Chun-yun, HU Jin-fang
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1282-1289. https://doi.org/10.16155/j.0254-1793.2025-0544
    Objective: This paper aims to establish a single bioanalytical method applicable for detecting anti-drug antibodies to insulin glargine and its biosimilar. Methods: The enzyme-linked immunosorbent assay was established by using biosimilars as both the capture antigen and the competitive antigen in the confirmation assay, as well as peroxidase-conjugated recombinant protein A/G as the detection reagent. The method validation was carried out from the aspects of antigen equivalence, screening cutoff, titer cutoff, confirmatory cutoff, sensitivity, precision, selectivity, hook effect, stability, and system adaptability. Results: Antigen equivalence (titration similarity and inhibition similarity) cross validation showed that the binding ability of biosimilars and reference drugs exhibited similar binding ability to positive antibodies. The screening cutoff factor was 1.186; the titer cutoff factor was 1.454; the confirmatory cutoff was 10.7%. The sensitivities of the screening assay and confirmatory assay were 8.9 ng · mL-1 and 7.7 ng · mL-1, respectively. The intra-plate and inter-plate relative standard deviations (RSDs) were less than 20% (The RSD of intra-plate precision of inhibition rate in the negative samples in the confirmation assay was 20.0%-22.8%, excluded). There was no hook effect in the range of 0.8-6.4 μg · mL-1. The samples were stable at room temperature for 3 h, refrigerated (2-8 ℃) for 1 d, and at -70 ℃ after four freeze-thaw cycles. Selectivity, drug tolerance, and system suitability were satisfactory. Conclusion: In this study, a single bioanalytical method applicable for detecting anti-drug antibodies to insulin glargine and its biosimilar is successfully established by the antigen equivalence verification of biosimilar and reference drugs.
  • Review & Monography
    HU Xiao-wen, YUAN Song, LIU Bo, LI Xiu-ji, WANG Song-yuan, LIU Yang, SUN Hui-min, CHEN Hua
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1373-1379. https://doi.org/10.16155/j.0254-1793.2025-0508
    Objective: To develop a high-precision and interpretable drug mutagenicity prediction model based on AI to assist in new drug development and pharmaceutical regulatory oversight. Methods: Mutagenicity data from various sources were collected and integrated to establish a standardized dataset of small organic molecules. A graph neural network framework was employed to train the model on the training set, while an external test set was used to evaluate its generalization capability. The applicability domain of the model was defined based on molecular fingerprint features and the convex hull algorithm was employed to assess prediction reliability. Additionally, an atomic perturbation-based analysis was conducted to investigate the prediction mechanisms of the model. Finally, a web server was developed as an internal mutagenicity prediction platform. Results: The optimized AI model achieved the accuracy of 0.828, recall of 0.863, precision of 0.848, and an area under the receiver operating characteristic curve of 0.907 on the training set. On the external test set, these metrics were 0.751, 0.789, 0.798, and 0.775, respectively. Furthermore, the model successfully identified key toxic structures or groups in compounds, such as sulfonate esters, nitrosamines, halogenated alkanes, and hydrazines, and effectively distinguished between samples within and outside the applicability domain. Furthermore, an online prediction platform was established, enabling toxicity assessment via molecular structures. Conclusion: The proposed model not only accurately predicts compound mutagenicity but also visualizes the potential risk sites, demonstrating robust generalization ability and practical utility. This study provides an efficient AI-driven solution for the early screening of genotoxic impurities.
  • Safety Monitoring
    XU Hong, LI Qiu-yue, HUANG Lin, LIN Li-kun, LI Guo-chun
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(6): 1133-1139. https://doi.org/10.16155/j.0254-1793.2025-0292
    Objective: To investigate the compatibility and stability of betahistine hydrochloride injection with 5 basic infusion solutions [sodium chloride 0.9% (NS), 5% glucose (5% GS), glucose and sodium chloride (GNS), compound sodium chloride (R), and 10% glucose (10% GS) Injections] within 24 h. Methods: Betahistine hydrochloride injection was admixed with these 5 kinds of infusion solutions, respectively. Then, the following changes at room temperature within 24 hours were examined: appearance (color, Tyndall effect), pH value, osmotic pressure, insoluble particles, active ingredient percentage content, and related substances. Results: The appearance, insoluble particles, active ingredient percentage content, and related substances of each compatibility solution met the requirements within 24 hours. For osmolality, the injection with NS and R was in the normal range of plasma osmolality (285-310 mOsmol · kg-1), the injection with 5% GS was slightly lower than 285 mOsmol · kg-1, and the injection with 10% GS and GNS was higher than 310 mOsmol · kg-1, while the osmolality of all the admixtures was in the tolerance of human body (140-830 mOsmol · kg-1). The pH of the injection with NS, 5% GS, GNS, and R remained within the intravenous infusion control range of 4-9 within 24 h, whereas the pH of the injection with 10% GS was below 4. Conclusion: NS and R are recommended as compatibility solutions for betahistine hydrochloride injection due to the physicochemical compatibility and stability of these compatibilities within 24 h. When admixed with 5% GS, GNS, or 10% GS, vigilance is warranted against potential adverse reactions, including vascular injury, hemolysis, and phlebitis.
  • Metabolism Analysis & Activity Analysis
    LIU Yu-ting, HOU Jia-hao, WANG Chao-hui, YU Yin-feng, YANG Ji-xia, SONG Yong-xing, FENG Chao, MA Dong-lai
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1258-1271. https://doi.org/10.16155/j.0254-1793.2025-0498
    Objective: To establish the HPLC fingerprints of Lycii Cortex from different origins, study the glucose-lowering activity-fingerprint relationship of Lycii Cortex, and preliminarily clarify the main active ingredients of Lycii Cortex for lowering glucose. Method: A Zorbax SB-AQ C18 column (250 mm×4.6 mm, 5 μm) at a column temperature of 40 ℃ was used for gradient elution with a mobile phase consisting of acetonitrile-0.1% trifluoroacetic acid aqueous solution at a flow rate of 1.0 mL · min-1. The detection wavelength was set as 280 nm, and the injection volume was 10 μL. HPLC fingerprinting was performed for nine components—caffeoylputrescine, chlorogenic acid, scopolin, vanillic acid, kukoamine B, kukoamine A, ferulic acid, cinnamic acid, and N-trans-feruloyltyramine—in 25 batches of Lycii Cortex samples from different geographical origins. Hierarchical cluster analysis (HCA), principal component analysis (PCA), and orthogonal partial least squares-discriminant analysis (OPLS-DA) were employed to distinguish and compare Lycii Cortex samples from various origins and to identify the main differential components. An insulin-resistant HepG2 (IR-HepG2) cell model was established with insulin, and the glucose oxidase method and CCK-8 assay were used to determine the appropriate treatment concentration of Lycii Cortex for this model. Glycogen content, hexokinase (HK) activity, and pyruvate kinase (PK) activity were measured after treatment with Lycii Cortex samples from different origins. An activity-fingerprint relationship model linking the marker components of Lycii Cortex from various origins to their glucose-lowering effects on IR-HepG2 cells was constructed through grey relational analysis and partial least squares regression (PLSR). Results: The HPLC fingerprints of Lycii Cortex were constructed, showing 28 common peaks, among which 9 chemical components were identified. The results of grey relational analysis indicated that the glucose-lowering effect was a synergistic effect of multiple components. The results of PLSR showed that there were six peaks with VIP>1, including peaks 9 (kukoamine B), 4, 10 (kukoamine A), 12, 5 (caffeoylputrescine), and 1, which were positively correlated with glucose-lowering activity. Conclusion: The analysis of the activity-fingerprint relationship preliminarily clarifies the glucose-lowering substance basis of Lycii Cortex and provides a scientific reference for its quality control.
  • Ingredient Analysis
    WU Yue, MA Chi, KONG Ling-jie, ZHANG Wei-dong
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1412-1419. https://doi.org/10.16155/j.0254-1793.2025-0785
    Objective: To establish an ultra-performance liquid chromatography-triple quadrupole mass spectrometry (UPLC-QQQ MS/MS) method for the simultaneous determination of nine blood-absorbed components in Qijiao Shengbai capsules, including 7-hydroxy-4-benzopyrone, calycosin, formononetin, medicarpin, p-coumaric acid, daidzein, maackiain, emodin, and icaritin. Methods: Chromatographic separation was performed on a Waters Acquity UPLC HSS T3 column (150 mm×2.1 mm, 1.8 μm) using gradient elution, with 0.1% formic acid in water (A) and acetonitrile (B) as the mobile phase and column temperature at 30 ℃. The flow rate was 0.2 mL · min-1,and the injection volume was 2 μL. Mass spectrometry was carried out using an electrospray ionization (ESI) source, and both positive- and negative-ion scanning were performed in multiple reaction monitoring (MRM) mode. Results: The established method showed good linear relationships (r≥0.998 1) and demonstrated good precision, repeatability, and stability (RSD<5.0%). The average recoveries (n=6) of the nine blood-absorbed components ranged from 97.3% to 107.2% with RSDs under 5.0%. The content ranges of the nine compounds in three batches of Qijiao Shengbai capsules were 0.271 2-0.275 3 μg · g-1, 139.9-146.5 μg · g-1, 42.31-43.80 μg · g-1, 5.817-5.946 μg · g-1, 6.740-7.145 μg · g-1, 1.206-1.246 μg · g-1, 42.83-44.78 μg · g-1, 0.364 4-0.387 0 μg · g-1, and 2.787-2.967 μg · g-1. Conclusion: The established method is specific, sensitive, and stable. It can be used to simultaneously determine the contents of nine blood-absorbed components in Qijiao Shengbai capsules, providing a scientific basis for its quality control and safe medication.
  • Bioassay
    CUI Chun-bo, DU Jia-liang, LI Xin, NI Yong-bo, XU Gang-ling, YU Chuan-fei
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1483-1489. https://doi.org/10.16155/j.0254-1793.2025-0493
    Objective: To establish a method for determining the content of poloxamer 188 added in panitumumab based on high performance liquid chromatography-evaporative light scattering detector (HPLC-ELSD). Methods: The content of poloxamer 188 was determined through an Oasis wax column (20 mm×2.1 mm, 30 µm/80 Å) at a column temperature of 30 ℃. Gradient elution was performed with 0.2% formic acid aqueous solution as mobile phase A and acetonitrile containing 0.2% formic acid as mobile phase B at a flow rate of 1.0 mL · min-1. The ELSD was used. Results: The specificity of the method was strong. In the range of 5 to 80 μg · mL-1, the logarithm of the content of poloxamer 188 was linearly correlated with the logarithm of the peak area, with a coefficient of determination r2>0.99. The recovery rates of the six validation solutions with different poloxamer 188 content (5 μg · mL-1,10 μg · mL-1, 20 μg · mL-1, 40 μg · mL-1, 60 μg · mL-1, and 80 μg · mL-1) were in the range of 90.0%-110.0%. Three independent measurements were carried out on three different working days for each of the six validation solutions mentioned above, and the RSDs for their concentrations were 4.4%, 5.5%, 2.3%, 0.66%, 1.6%, and 1.6%, respectively. The injection was repeated six times for the validation solution at 40 μg · mL-1, and the RSD of their poloxamer 188 content was 0.60%. The RSD of the poloxamer 188 content was 0.80% for the validation solution at 40 μg · mL-1, which was assayed after storage for 0 h and 24 h at room temperature, respectively. Conclusion: An HPLC-ELSD method for content deter mination of poloxamer 188 in monoclonal antibody drugs was successfully developed, demonstrating good reproducibility, specificity, precision, and accuracy, which can provide a reliable technical basis for the quantitation and quality control of poloxamer 188 in monoclonal antibody drugs.
  • Safety Monitoring
    LIU Bin, HUANG Wan, GUO Li, WANG Fan, WU Bing-chan
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1337-1345. https://doi.org/10.16155/j.0254-1793.2025-0625
    Objective: To establish an ultra-high performance liquid chromatography-triple quadrupole mass spectrometry (UPLC-QQQ MS/MS) method for the simultaneous determination of 10 aminoglycoside antibiotics in water. Methods: Following alkaline desorption of particulates in the water sample, heptafluorobutyric acid was added to form an ion pair with the target analytes, and then the ion pair was determined by the UPLC-QQQ MS/MS method. The analytes were separated on a Poroshell 120 SB-C8 chromatographic column (100 mm×3.0 mm, 2.7 μm) by gradient elution, with the mobile phase of 1 mmol · L-1 ammonium acetate and 0.1% (volume fraction) formic acid aqueous solution and acetonitrile. Then, the target analytes were ionized by electrospray ionization in positive ion mode, detected in multiple reaction monitoring mode, and quantified by the internal standard method. Key influencing factors, including sample stability, storage container, particulate matter in samples, solution pH, filter membranes, residual chlorine content in samples, and liquid chromatographic conditions, were systematically evaluated, and spiked water samples of five types of matrices were determined. Results: Samples can be stored sealed, refrigerated, and protected from light at below 4 ℃ for at least seven days, and plastic containers shall be used for storage. Aminoglycoside antibiotics tended to be adsorbed onto particulate matter, so alkaline desorption was required, and the filtrate must be adjusted to neutral before determination. A 0.22 μm polypropylene filter membrane shall be used for sample filtration. Residual chlorine can cause loss of the target analytes, and ascorbic acid must be added immediately after water sample collection. After optimizing instrumental conditions, limits of detection ranged from 1.0 to 1.7 μg · L-1. Recovery tests were conducted using the standard addition method. Except for spectinomycin, which showed slightly lower recoveries in complex matrices (with average recoveries of 42.8% and 41.0% in domestic sewage and industrial wastewater, respectively), the recoveries of the other compounds in all matrices, as well as those of spectinomycin in pure water, groundwater, and surface water matrices, ranged from 60.0% to 127.0%. The relative standard deviations (RSDs) (n=6) were between 1.3% and 16.0%. Conclusion: All performance parameters of this method satisfy current quality-control requirements for environmental antibiotic monitoring and thus are of practical referential significance.
  • Safety Monitoring
    LI Xiao-xin, CAI Jian-lei, LI Qiong-xia, LU Jun-qi
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1490-1497. https://doi.org/10.16155/j.0254-1793.2025-0413
    Objective: To evaluate the residual levels and health risks of heavy metals and harmful elements in blood-activating traditional Chinese medicine (TCM) preparations containing insect-based drugs, thus providing a scientific basis for clinical safe medication and quality control of TCM preparations. Methods: Inductively coupled plasma mass spectrometry (ICP-MS) was employed to determine the content of lead (Pb), cadmium (Cd), arsenic (As), mercury (Hg), copper (Cu), vanadium (V), cobalt (Co), and nickel (Ni) in 97 batches of blood-activating TCM preparations containing insect-based drugs. Multivariate statistical analysis, one-way analysis of variance (ANOVA), principal component analysis (PCA), and health risk assessment models were combined to systematically evaluate the non-carcinogenic and carcinogenic risks of these elements. Results: The 75th percentile (P75) values of Pb, Cd, As, Hg, Cu, V, Co, and Ni in the 97 batches of TCM preparations were 5.04, 0.365, 3.80, 0.039 0, 30.2, 1.14, 1.38, and 4.63 mg · kg-1, respectively. Significant differences in the hazard levels of various elements were observed among different varieties. Multivariate statistical analysis, one-way ANOVA, and robustness testing all yielded P-values less than 0.05 and effect sizes greater than 0.04. PCA results indicated that Cd, As, Hg, and Cu were the major contributors to health hazards. The LCR values for carcinogenic risks in all varieties of TCM preparations were less than 1×10-6, within an acceptable range. Among non-carcinogenic risks, Pb in Tongxinluo capsules and Qizhi Tongluo capsules showed the hazard index (HI) greater than 1, which warranted attention. Conclusion: The carcinogenic risks of 97 batches of TCM preparations are relatively low. In terms of non-carcinogenic risks, the exposure to Pb in Tongxinluo capsules and Qizhi Tongluo capsules deserves further attention. This study provides a reference for the safety evaluation of TCM preparations.
  • Ingredient Analysis
    ZHENG Wen-wei, WANG Li-na, XIE Jing-xin, ZHOU Ji-xuan, ZHANG Kuan, YAN Jin-xian
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1202-1215. https://doi.org/10.16155/j.0254-1793.2025-0545
    Objective: To establish a quality evaluation method for compound Shihu Xiaoke granules by combining HPLC fingerprinting, quantitative analysis of 21 components, chemometrics, and entropy-weighted TOPSIS, thereby providing a basis for improving its quality standards. Methods: A Thermo Scientific AccucoreTM XL C18 column (250 mm×4.6 mm, 4 μm) was used at 30 ℃ for gradient elution with a mobile phase of acetonitrile-0.2% phosphoric acid aqueous solution at a flow rate of 1.0 mL · min-1, a detection wavelength of 265 nm, and an injection volume of 10 μL. The HPLC fingerprints of compound Shihu Xiaoke granules were established, and a quantitative analysis method for 21 components was developed and validated. With the obtained data, hierarchical cluster analysis (HCA), principal component analysis (PCA), orthogonal partial least squares-discrimination analysis (OPLS-DA), and entropy-weighted TOPSIS were then employed to evaluate the quality of 15 batches of samples. Results: Methodological validation confirmed that the established fingerprints and quantitative analysis methods met analytical requirements. The similarity of fingerprints for 15 batches of compound Shihu Xiaoke granules ranged from 0.982 to 0.999, with 36 common peaks, of which 21 were identified. HCA, PCA, and OPLS-DA yielded consistent results, clustering the 15 batches into three main categories. With the threshold of variable importance for the projection (VIP)>1, 22 potential differential markers were screened out. The average content of the 21 quantified components—gallic acid, danshensu, protocatechuic acid, protocatechualdehyde, 3'-hydroxypuerarin, caffeic acid, puerarin, mangiferin, 3'-methoxypuerarin, puerarin-6"-O-glucoside, puerarin apioside, daidzin, glycitin, calycosin glucoside, genistin, rosmarinic acid, lithospermic acid, daidzein, salvianolic acid B, calycosin, and salvianolic acid A—ranged from 0.012 mg · g-1 to 2.129 mg · g-1. The entropy-weighted TOPSIS evaluation indicated that batch S5 had the best quality. Conclusion: The established fingerprint and quantitative analysis method for 21 components are accurate, reliable, and reproducible. The approach combining HPLC fingerprinting, quantitative analysis of 21 components, chemometrics, and entropy-weighted TOPSIS enables comprehensive and objective quality evaluation of compound Shihu Xiaoke granules, providing a new technical means for quality control of this preparation.
  • Review & Monography
    WANG Shu-ting, WANG Xiao-sen, LÜ Jun, JIN Hong-tao
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1180-1189. https://doi.org/10.16155/j.0254-1793.2025-0679
    In recent years, the abuse of etomidate has become increasingly serious. With etomidate being listed in the control catalog, the synthesis of non-scheduled analogues by modifying the chemical structure has become an emerging abuse trend to evade regulation, posing a serious threat to public health and safety. In the face of the increasing types of abuse, it is particularly important to strengthen the regulation and detection of etomidate and its analogues. Based on a systematic summary of the pharmacological and toxicological properties of etomidate, this paper focuses on the structure-activity relationships and detection methods of etomidate and its analogues, with the expectation of providing references for the establishment of control strategies and analytical methods for etomidate.
  • Safety Monitoring
    SU Dan, WANG Hui-li, ZHANG Rui-xian, CONG Hai-long, BAI Ming-zhu, LI Ying, ZHANG Hai-yan, WANG Cheng-yao
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1540-1550. https://doi.org/10.16155/j.0254-1793.2025-0455
    Objective: To determine the content of five heavy metals and harmful elements—copper (Cu), arsenic (As), cadmium (Cd), mercury (Hg), and lead (Pb)—in eight Mongolian medicinal materials (Heibingpian, Oxytropis myriophylla (Pall.) DC., Scabiosa comosa Fisch. ex Roem. et Schult., Lomatogonium rotatum (L.) Fries ex Nym., Syringa pinnatifolia Hemsl. var. alashanensis Ma et S. Q. Zhou, Liquidambar formosana Hance, Vladimiria souliei (Franch.) Ling, Dracocephalum moldavica L., 40 batches in total) circulated in Hohhot, analyze their pollution status, and establish a risk assessment model. Methods: The content of heavy metals and harmful elements in the 40 batches of Mongolian medicinal materials was measured through inductively coupled plasma mass spectrometry (ICP-MS). Element concentrations and pollution indices were determined to assess pollution levels, and the target hazard quotient (THQ) and carcinogenic risk (CR) were adopted to evaluate non-carcinogenic and carcinogenic risks, respectively. Results: Among the 40 batches of Mongolian medicinal materials, Heibingpian exhibited the highest total content of heavy metals and harmful elements, which ranged from 21.478 mg · kg-1 to 33.330 mg · kg-1.The Cu, As, and Pb content was ND (not detected)-21.936 mg · kg-1, ND-2.351 mg · kg-1, and 0.035-8.834 mg · kg-1,respectively. The content of Cd and Hg in all the samples did not exceed the limit standards. The average Pb content in Heibingpian was 8.035 mg · kg-1, and the content of As and Cu in Heibingpian was close to the threshold limits. The pass rate of heavy metal and harmful element tests for the other seven tested Mongolian medicinal materials except Heibingpian reached 100%. Non-carcinogenic risk assessment revealed that the THQ values of the five elements in Heibingpian and As in O. myriophylla exceeded the standard limits, indicating potential health risks. The CR values of all tested medicinal materials were far below the safety threshold (1×10-6), suggesting negligible carcinogenic risks. Conclusion: Mongolian medicinal materials circulated in Hohhot in this study are generally safe. Special attention should be paid to the health risks posed by heavy metals in individual medicinal materials such as Heibingpian and O. myriophylla, and stricter supervision on raw material traceability and processing procedures is required. The multi-element analytical method and multi-index evaluation system constructed in this study can provide scientific references for pollution monitoring and risk management of heavy metals in Mongolian medicinal materials.
  • Bioassay
    TAN Jin-chao, WANG Li-chan, WEI Chen, LI Zhe, YUAN Li-yong, TAN Ya-jun, GUO Jing, MA Xiao
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(6): 969-981. https://doi.org/10.16155/j.0254-1793.2026-0151
    Objective: To comprehensively characterize the adaptively evolved epidemic strains of Bordetella pertussis at gene and protein levels via RNA sequencing and liquid chromatography-tandem mass spectrometry, investigate characteristic variations of the strains under China’s pertussis vaccination background, and analyze the functional impacts of these changes based on in vivo experimental findings. Methods: Two major epidemic strains (BRK197 and BRK202) of Bordetella pertussis were characterized from bacterial growth patterns and antigen expression profiles. Bacterial growth curves were established to observe proliferation characteristics. RNA sequencing was employed to detect expression trends of genes associated with metabolism, toxins, toxin regulation, and toxin secretion during different growth phases, as well as expression differences of key mutated antigen genes. Liquid chromatography-tandem mass spectrometry was employed to quantify key antigenic protein expression levels. Western blotting of strain fermentation liquids was adopted to verify structural integrity of mutated antigenic proteins. Results: The two epidemic strains exhibited distinct growth and antigen expression patterns in vitro. Specifically, the proliferation and toxin expression of BRK197 peaked in the late logarithmic phase, while those of BRK202 peaked in the early logarithmic phase. Adaptive mutations significantly affected antigen expression levels. Under identical culture conditions, the ptxP3-type strain BRK197 showed higher expression level of the pertussis toxin antigen (P≤0.05), and the fha3-type strain BRK202 exhibited reduced expression of filamentous hemagglutinin antigen (P≤0.01). The mutant antigen protein bands were normally expressed in the epidemic strains, and gene mutations did not disrupt the structural integrity of proteins. Conclusion: Under China’s pertussis vaccination pressure, differentially evolved epidemic strains (BRK197 and BRK202) exhibit distinct characteristics. BRK197 demonstrates stronger toxin-producing capacity, while BRK202 displays enhanced host adaptability in vitro. These differences likely contribute to increased infectivity and pathogenicity during in vivo infection. Adaptive mutations directly affect the expression levels of key antigens, and the ptxP3-type strain can highly express pertussis toxin antigen. Notably, the insertion of VAAPA at amino acid position 2 318 in the filamentous hemagglutinin antigen antigen of the fha3-type strain may lead to low detection levels of filamentous hemagglutinin antigen expression.
  • Safety Monitoring
    LIANG Chun-jun, HUANG Yu-mei, TU Dong-ping, LIANG Chen-yan, LU Juan, ZHU Yi-lin, WANG Liu-ping, YAN Zhi-gang
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1524-1531. https://doi.org/10.16155/j.0254-1793.2025-0577
    Objective: To establish a method for identifying Epiphyllum oxypetalum (DC.) Haw. and its adulterant Hylocereus undatus (Haw.) Britt. et Rose to ensure the accuracy and safety of clinical medication. Methods: E. oxypetalum and its adulterant H. undatus were compared by original plant identification, morphological characterization, and optical microscopy and pathological section scanning imaging for microscopic characteristics of roots, stems, flowers, and powder. Results: Significant differences exist between E. oxypetalum and H. undatus in terms of original plant features, macroscopic characteristics of medicinal materials, and microscopic characteristics. The two species can be distinguished by the morphological characteristics of their roots, stems, flowers, hypanthia, and fruits, and they exhibit obvious differences in texture, odor, and color of medicinal materials. Furthermore, distinct differences were observed in the transverse sectional tissue structures of roots, leaf-like stems, hypanthia, styles, and perianths, as well as in the powder microscopic characteristics of the two medicinal materials. Conclusion: E. oxypetalum and its adulterant H. undatus can be effectively identified by the differences in traits and microscopic characteristics, which can provide reference for the safe medication and further development and utilization of E. oxypetalum.
  • Metabolism Analysis & Activity Analysis
    LIU Bin, FENG Xue, ZHANG Cai-juan, WANG Dun-fang, LIU Hai-fan, ZHU Lin, LIU Jian-yao, SUN Qi-yue, YANG Wei-peng
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1246-1257. https://doi.org/10.16155/j.0254-1793.2025-0421
    Objective: To conduct a qualitative study on the chemical components of Ganlu Xiaodu Dan and its blood- and brain-entering components using ultra-high-performance liquid chromatography-quadrupole/electrostatic field Orbitrap high-resolution mass spectrometry (UHPLC-Q Exactive Orbitrap HRMS). Methods: UHPLC-Q Exactive Orbitrap HRMS was employed to identify the chemical components of Ganlu Xiaodu Dan. Twelve male Sprague-Dawley (SD) rats were randomly divided into a blank group and a Ganlu Xiaodu Dan group. The Ganlu Xiaodu Dan group received an intragastric administration of the aqueous decoction at a raw herb dose of 1.8 g · kg-¹, while the blank group received an equivalent volume of purified water. Plasma samples were collected 1.5 h post-administration. Using an ACQUITY UPLC HSS T3 column (100 mm×2.1 mm, 1.8 µm) at a column temperature of 40 ℃. The mobile phase consisted of 0.1% formic acid in water and acetonitrile with gradient elution at flow rate of 0.30 mL · min-1. The injection volume was 6 µL. Electrospray ionization (ESI) was applied with a scanning range of m/z 100-1 500. Combined with information from a reference database, qualitative analysis of blood-entering components was performed in both positive and negative ion modes. Results: A total of 195 compounds were identified in the 80% methanol extract of Ganlu Xiaodu Dan, and 66 prototype components were detected in serum. The fragmentation patterns of baicalin, apigenin-7-glucoside, isorhamnetin-3-O-galactoside, biochanin A, 28-deacetylbelamcandal, plantamajoside A, phillyrin A, aurantio-obtusin, neochlorogenic acid, chrysosplenol, mangiferin, and chuanbeiketonine were analyzed. Conclusion: This study enabled the rapid characterization and identification of multi-category in vitro chemical components and blood-entering components of Ganlu Xiaodu Dan, providing a reference for research on its pharmacodynamic material basis and quality control.
  • Safety Monitoring
    SUN Xiao-li, LI Tie-jun, JIANG Ming-ming, SUN Ying-ji, GENG Qian-qian, BI Yan-kun
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1532-1539. https://doi.org/10.16155/j.0254-1793.2025-0523
    Objective: To identify impurities in the starting material of paliperidone by LC-MS, analyze the impurities in combination with the synthetic process, and establish a HPLC method for the determination of related substances in the starting material of paliperidone. Methods: LC-MS was performed with an Agilent Eclipse XDB-C18 column (250 mm×4.6 mm, 5 μm) at a column temperature of 40 ℃. Gradient elution was performed with 0.1% formic acid solution as mobile phase A and water-acetonitrile (10 ∶ 90) as mobile phase B at a flow rate of 1.0 mL · min-1. The detection wavelength was set at 238 nm, the injection volume at 20 μL, and the sample tray temperature at 10 ℃. For HPLC, an Agilent Eclipse XDB-C18 chromatographic column (250 mm×4.6 mm, 5 μm) at a column temperature of 40 ℃ was used for gradient elution with the mobile phase A consisting of 3.4 g · L-1 potassium dihydrogen phosphate solution (adjusted to pH 4.0 with phosphoric acid), methanol, and acetonitrile at a ratio of 90 ∶ 5 ∶ 5 and the mobile phase B being a mixture of acetonitrile and methanol (50 ∶ 50) at a flow rate of 1.0 mL · min-1. The detection wavelength was set as 238 nm, the injection volume as 20 μL, and the sample tray temperature as 10 ℃. Results: Five impurities in the starting material of paliperidone were detected by LC-MS. The five known impurity reference standards showed good linear relationships within a certain concentration range in the HPLC method. The resolution between peaks was greater than 1.5. The limits of detection (LOD) of each component ranged from 0.009 2 to 0.032 8 μg · mL-1. The recovery rates of all impurities were between 90% and 108%. The relative standard deviations (RSDs) of impurity recovery rates in the precision test were no more than 6%. The test solution remained stable when being stored at 10 ℃ for 4 h. The method had satisfactory robustness. Five batches of samples were determined. The detected content of impurity ii-1, impurity ii-2, impurity ii-3, impurity ii-4, and impurity ii-5 was 0.04%-0.26%, 0-0.16%, 0-0.24%, 0, and 0-0.24%, respectively. The content of other single impurity was 0.13%, and the total impurity content was 0.17%-0.53%. Conclusion: This method possesses strong specificity, high sensitivity, and high accuracy, being suitable for the determination of related substances in the starting material of paliperidone.
  • Standard Deliberation
    YU Meng, WANG Si-jin, ZHANG Xun-di, MA Shi-hong
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1363-1372. https://doi.org/10.16155/j.0254-1793.2025-0445
    Objective: To rapidly identify the contamination risk from Burkholderia cepacia complex (Bcc) during pharmaceutical production, a real-time fluorescent quantitative PCR (RT-qPCR) detection method based on the hutC gene was developed. Methods: The nucleotide sequences of the hutC gene from Bcc and its related species were analyzed. Specific TaqMan probes and primers targeting the conserved regions of the hutC gene were designed, and an internal amplification control (IAC) probe was also constructed. The reaction system and conditions were optimized. The established method was validated using Bcc and non-Bcc strains, and parameters including specificity, amplification efficiency, and detection limit were evaluated. Both pharmacopoeia methods and the established RT-qPCR methods were used to detect Bcc in 20 artificially contaminated water-based products. Results: In the optimized reaction system, the final concentrations of both forward and reverse primers were 200 nmol · L-1; the final concentrations of hutC probe and IAC probe were 200 nmol · L-1 and 400 nmol · L-1, respectively, with 1 μL of IAC template DNA at a concentration of 1.3×10-5 ng · μL-1 added to each reaction. In the experiments, specific amplification was observed for all 12 Bcc strains, while no specific amplification was detected for the 21 non-Bcc strains, including closely related species within the same genus, pharmacopoeia specified control bacteria, and common Gram-negative bacteria isolated from water systems. When IAC was introduced, the amplification efficiency was 101% for the hutC recombinant plasmid and 88% for B. cepacia ATCC 25416 culture. The detection limit was 14 CFU · reaction-1. The qualitative detection results of the 20 artificially contaminated water-based products obtained by the developed method were consistent with those of the pharmacopoeia method, whereas the detection time was reduced from 6-7 d (pharmacopoeia method) to 24 h. Conclusion: The established RT-qPCR method can serve as a risk control approach in pharmaceutical production, enabling rapid and specific detection of Bcc contamination in high-risk water-based products, in-process materials, and raw materials.
  • Bioassay
    SONG Ming-hui, WEI Ze-yu, GUAN Zi-qiu, FAN Yi-ling, SHAO Hong
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1472-1482. https://doi.org/10.16155/j.0254-1793.2025-0456
    Objective: To systematically investigate the design of aseptic process simulation intervention activities applicable to cell therapy medicinal products (CTMPs), represented by chimeric antigen receptor T-cell (CAR-T) products, identify potential contamination risks during the manufacturing process, and improve aseptic assurance capabilities. Methods: Regulations and technical guidelines issued by major regulatory agencies in China and abroad were systematically reviewed, and differences in their applicability to CTMPs were analyzed. Based on a scientific risk assessment approach, an intervention risk assessment model was applied to identify and classify intervention activities during the CAR-T manufacturing process. Key intervention points were then incorporated into the design of aseptic process simulation trials to develop a targeted simulation plan. Results: This study identified key intervention activities in the aseptic process simulation design of CTMPs represented by CAR-T products, established a quantifiable risk assessment matrix for intervention activities, and provided a scientific approach for identifying potential contamination risks during CTMPs manufacturing processes, thereby enhancing the effectiveness of aseptic process simulation trials for CTMPs. Conclusion: This study provides a technical basis for optimizing the aseptic assurance system of CTMPs represented by CAR-T products, offers guidance for the development of standardized practices in related industries, and provides a reference for the revision of relevant technical guidelines.
  • Bioassay
    LI Dan-xi, WANG Jin, LIU Bo, WANG Yi-ping, NING Bao-ming, YANG Hui-ying, WU Xian-fu, SUN Hui-min
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1272-1281. https://doi.org/10.16155/j.0254-1793.2026-0072
    Objective: To establish an analytical method based on ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry (UPLC-Q TOF MS/MS) for the sequence determination of CpG oligodeoxynucleotide (CpG ODN) immune adjuvants, thereby providing technical support for their quality control and quality consistency evaluation. Methods: The CpG ODN HP 007 was used as the sample for analysis by UPLC coupled with high-resolution mass spectrometry. The trimethylamine-hexafluoroisopropanol ion pair system was utilized as the mobile phase, which was separated by gradient elution through the C18 column. The MS data were collected in the electrospray negative ion mode to obtain accurate molecular weight information. On the basis of screening of different charge state parent ions, a single specific parent ion independent targeted acquisition strategy was employed to obtain characteristic fragments from the MS2 spectrum. Subsequent to data acquisition, deconvolution, fragment ion recognition, and sequence matching were carried out. Thereafter, a multi-dimensional index comprehensive judgment framework integrating sequence coverage, fragment matching continuity, and confirmation status was constructed to confirm the target sequence. Results: The measured molecular mass of HP 007 was 9 345.51, which closely matched the theoretical molecular mass of the target object sequence (9 345.5). The fragment information generated by different charge state parent ions exhibited significant complementarity. The implementation of a multi-parameter comprehensive judgment strategy has been demonstrated to facilitate the reliable confirmation of target sequence. Conclusion: The UPLC-Q TOF MS/MS sequence confirmation method integrating multi-charge state parent ion analysis and multi-parameter comprehensive evaluation established in this study enhances the reliability of ODN sequence confirmation. It compensates for the limitations of the single coverage index in sequence determination. Furthermore, it can serve as a reference for sequence confirmation and quality control of CpG ODN vaccine adjuvants.
  • Ingredient Analysis
    WEI Li-fang, LIN Qing, ZHANG Chi, HUANG Shi-ying, LI Chang-hui, WANG Rui, WU Jin-ru, HUANG Hai-piao, CHEN Qiu-gu, CHEN Jian-ping
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(6): 1025-1037. https://doi.org/10.16155/j.0254-1793.2025-0397
    Objective: To establish a high-performance liquid chromatography coupled to triple quadrupole mass spectrometry (HPLC-QTRAP-MS/MS) method for determining the contents of 42 main components in Xiao-Er-An-Shen-Bu-Nao granule, clarify their chemical composition, and analyze the consistency of its preparations. Methods: The Thermo Scientific Hypersil GOLD chromatographic column (150 mm×4.6 mm, 3 μm) was employed in HPLC. Gradient elution was performed with the mobile phase of 0.1% formic acid aqueous solution and methanol at a column temperature of 35 ℃ and a flow rate of 0.4 mL · min-1. The multiple reaction monitoring (MRM) ion scanning mode was operated to detect in the mass spectrometer. Based on the contents of 42 target components, principal component analysis (PCA), hierarchical cluster analysis (HCA), and content fluctuation of target components (P value) were further employed for the consistency analysis of the preparation. Results: Based on the established HPLC-QTRAP-MS/MS method, the simultaneous quantitative analysis of 42 components in Xiao-Er-An-Shen-Bu-Nao granule could be performed, which included the main components of monarch, minister, assistant, and guide herbs of Xiao-Er-An-Shen-Bu-Nao granule in a relatively comprehensive way. The total contents of 42 components in nine batches of Xiao-Er-An-Shen-Bu-Nao granule samples ranged from 4 759.58 to 5 383.30 μg · g-1. Among them, the contents of flavonoids were the highest, accounting for 68.81%-72.58%, followed by organic acids, iridoid glycosides, and phenylpropanoids, and the contents of alkaloids were lower. PCA and HCA results showed that there were certain differences in different batches of Xiao-Er-An-Shen-Bu-Nao granule. Among the nine batches of Xiao-Er-An-Shen-Bu-Nao granule, the content of α-asarone fluctuated greatly with P value ranging from 27.75% to 235.75%, while the content of the other 41 components, such as hordenine, fluctuated within an acceptable range with P value ranging from 75% to 125%. Conclusion: The analytical method established in this study is rapid, with high sensitivity and reliable results, which could provide scientific methods and a basis for consistency analysis and quality control of Xiao-Er-An-Shen-Bu-Nao granule preparation.
  • Safety Monitoring
    AN Bai-feng, SONG Geng-shen
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1515-1523. https://doi.org/10.16155/j.0254-1793.2025-0796
    Objective: To establish a high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method for the simultaneous determination of the content of 5 genotoxic impurities in vonoprazan fumarate, thereby meeting the detection requirements for trace genotoxic impurities in this bulk drug. Methods: An Agilent ZORBAX Eclipse XDB-C18 column (4.6 mm×150 mm, 3.5 μm) was used for linear gradient elution with 0.1% formic acid aqueous solution as mobile phase A and acetonitrile containing 0.1% formic acid as mobile phase B at the flow rate of 0.5 mL · min-1, the column temperature of 30 ℃, and the injection volume of 10 μL. The mass spectrometry adopted electrospray mass ionization (ESI) and the multiple reaction monitoring (MRM) in the positive ion mode. Results: The linear relationships of various impurities were good within a certain concentration range (r: 0.995 0-0.999 7). The limit of detection and the limit of quantification reached 0.02-0.09 ng · mL-1 and 0.04-0.27 ng · mL-1, respectively. The accuracy test showed that the average recovery rates of various impurities were between 89.0% and 109.4%, and the relative standard deviations (RSDs) were all no more than 6.3%. The content of genotoxic impurities in multiple batches of samples were all considerably lower than 30% of the acceptable limit specified in ICH M7 (R2). Conclusion: The established HPLC-MS/MS method exhibits high sensitivity and strong specificity, enabling the simultaneous determination of five genotoxic impurities in vonoprazan fumarate. This method can be employed for the routine quality control of the above five genotoxic impurities in vonoprazan fumarate.
  • Ingredient Analysis
    WANG Xiao-fang, ZHAI Si-qi, ZHENG Qian-qian, ZHANG Li-ping, LIU Lin
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1216-1224. https://doi.org/10.16155/j.0254-1793.2025-0531
    Objective: To establish a ultra high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method for simultaneous determination of 13 chemical components (terrestrosin K, phellodendrine hydrochloride, imperatorin, isoimperatorin, prim-O-glucosylcimifugin, buddleoside, verbascoside, liquiritin, wogonin, geniposide, luteolin-7-O-glucoside, paeoniflorin, and baicalein) in Mingmu Jili pills. Methods: The separation was performed through a Waters Acquity BEH C18 column (100 mm×2.1 mm, 1.7 µm) with a column temperature at 40 ℃. The mobile phase consisted of acetonitrile-5 mmol · L-1 ammonium formate (containing 0.1% formic acid) with gradient elution at a flow rate of 0.3 mL · min-1. The injection volume was 1 µL. The detection was carried out by electrospray ionization (ESI) source combined with multiple reaction monitoring (MRM) in positive and negative ion modes. Results: The 13 components showed good linear relationships in their respective concentration ranges (r>0.999 0). The method demonstrated high precision, repeatability, and stability. The spiked recovery rates ranged from 93.7% to 110.0%, with the relative standard deviation (RSD) of 0.28%-9.7%. The content of 13 components in 13 batches of Mingmu Jili pills was 11.94-75.55, 66.88-156.32, 57.18-87.83, 18.57-27.68, 20.20-196.20, 230.73-485.25, 539.71-3 061.53, 24.30-87.02, 314.32-973.51, 297.45-1 736.38, 61.45-473.48, 397.44-1 275.18, and 331.81-4 091.77 µg · g-1. Conclusion: The established method is efficient, simple, accurate, and reproducible, which can provide a reference for the quality control of Mingmu Jili pills.
  • Bioassay
    HE Zhi-yong, ZHANG Xu-hong, FANG Li-na, ZHENG Xiao-ling
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1290-1298. https://doi.org/10.16155/j.0254-1793.2025-0723
    Objective: To conduct microbial monitoring and analysis of pharmaceutical water systems from three enterprises, and preliminarily explore culture media suitable for subculture of microorganisms isolated from these systems. Methods: A total of 130 microbial strains were isolated from the pharmaceutical water systems of three enterprises. Bacterial and fungal isolates were identified by 16S rDNA and ITS rDNA sequencing, respectively. Phylogenetic trees were constructed for frequently detected genera to analyze potential contamination sources. Furthermore, subculture studies were performed on all the 130 strains with three different culture media and the modified sterilization method. Results: The microorganisms most frequently detected in the water systems of the three pharmaceutical enterprises were Methylobacterium, Ralstonia, and Bradyrhizobium. Subculture results of the 130 strains showed that R3A and R2A media performed better than Tryptic Soy Agar (TSA). The sterilization method was modified as autoclaving phosphate and agar components separately before mixing in the R3A medium, which improved the growth rate of some slow growing microorganisms on RXA media. Conclusion: Microorganisms in pharmaceutical water systems show certain commonality. RXA media may be more suitable for subculture of microorganisms from pharmaceutical water systems. For some microorganisms susceptible to oxidative stress, modifying the sterilization method for the culture medium can promote their growth.
  • Bioassay
    OUYANG Zi-jun, XING Zhan-lei, HU Nan, HUANG De-feng, WANG Hui, CHEN Xi, LI Gang, SONG Lan-kun
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1299-1306. https://doi.org/10.16155/j.0254-1793.2025-0500
    Objective: To develop a LC-MS method for the quantitation of three free fatty acids—lauric acid, myristic acid, and oleic acid—in antibody pharmaceuticals based on the analytical quality by design (AQbD) principles outlined in the ICH Q14 guideline on analytical procedure development, and to perform subsequent method validation. Methods: The analytical target profile (ATP) was initially established. Based on literature review and laboratory experience, a 1290 UHPLC (ultra-high performance liquid chromatography) system coupled with an SQ- MS (single quadrupole mass spectrometer) was selected to develop the method. All operational steps, spanning from sample preparation to LC-MS detection, that could potentially influence analytical method performance were comprehensively identified, and their potential impact on method accuracy and precision was systematically assessed. With respect to the control strategy, factors associated with high risk or high operational cost were subjected to stringent control. Experimental investigations were conducted on chromatographic column selection, mobile phase composition, gradient or isocratic elution modes, column temperature, as well as mass spectrometric parameters including capillary voltage, fragmentor voltage, and nebulizer pressure. A quantitative analytical method suitable for the degradation products of polysorbate (Tween) was developed and subsequently validated in accordance with ICH Q2 requirements. Results: Methodvalidation demonstrated that the established LC-MS method for free fatty acid quantification exhibited spike recoveries ranging from 82.3% to 106.6% for lauric acid, myristic acid, and oleic acid. The linear range spanned from 0.01 to 2.00 μg · mL-1, with a lower limit of quantitation (LLOQ) below 0.01 μg · mL-1. No interference from proteinaceous components or excipients within the antibody formulation was observed. The method was applied to analyze the concentrations of lauric acid, myristic acid and oleic acid in both within-specification and expired antibody preparations, as well as in forced degradation samples from two investigational antibody formulations. Notably, significantly elevated levels of lauric acid, myristic acid, and oleic acid were detected in the forced degradation samples, indicative of polysorbate degradation. The method performance met the predefined requirements specified in the ATP, rendering it suitable for the quantitative detection of free fatty acids in diverse antibody pharmaceuticals. Conclusion: This study presents a case study of LC-MS method development employing AQbD principles. Through rigorous control of experimental materials, measurement procedures, and operational protocols, and via experimental verification of permissible ranges for mass spectrometer gas flow and voltage parameters, the final method specifies mass spectrometric parameters as acceptable operational ranges rather than discrete fixed values. This approach holds substantial value for the method lifecycle, particularly in the context of change management. The developed method is applicable to the quantification of free fatty acids derived from polysorbate degradation in antibody products. Furthermore, this case provides a meaningful reference for the application of LC-MS methodology in pharmaceutical quality control.
  • Standard Deliberation
    LI Ting, LI Min, LEI Zhen-hong, LI An-ping, CHENG Xian-long
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1354-1362. https://doi.org/10.16155/j.0254-1793.2025-0590
    Objective: To establish an ultra-performance liquid chromatography-triple quadrupole mass spectrometry (UPLC-QQQ MS) method for the rapid and simple qualitative identification of Qizhi Tongluo capsules. Methods: Gradient elution was performed through a Waters ACQUITYTM UPLC Hss T3 C18 column (100 mm×2.1 mm, 1.8 μm) with the mobile phase composed of acetonitrile and 0.1% formic acid aqueous solution at the flow rate of 0.3 mL · min-1 and the column temperature of 35 ℃. The chromatographic effluents were detected by mass spectrometry in positive and negative ion modes. Results: The specific chromatograms showed 32 common characteristic peaks from 13 Chinese herbal medicines. The structures of 23 characteristic components were confirmed by comparison with reference substances. RSDs of the relative retention time of 32 characteristic peaks in 10 batches of samples were all less than 1.0%, indicating that the 32 characteristic peaks were stable. Conclusion: The established liquid chromatography-mass spectrometry (LC-MS) specific chromatogram method is simple, sensitive, and accurate, comprehensively reflecting the chemical composition characteristics of Qizhi Tongluo capsules and serving as a new method for rapid identification of Qizhi Tongluo capsules.
  • Safety Monitoring
    LIU Jing-yu, DING Yi, LI Ya-nan, ZHANG Dan-dan, ZHANG Yun-zheng, ZHANG Yu-bi, WANG Xian-shu
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1320-1329. https://doi.org/10.16155/j.0254-1793.2025-0595
    Objective: To establish a rapid and sensitive method for determining As (Ⅲ) in Realgar, a commonly used Chinese medicinal material with safety mainly influenced by As (Ⅲ), thereby ensuring its safe use. Methods: An iron-cobalt layered double hydroxide/transition metal carbide (Fe-Co-LDH/MXene) nanocomposite was synthesized by a hydrothermal method. A glassy carbon electrode (GCE) was modified with this nanocomposite to fabricate a sensor (Fe-Co-LDH-MXene/GCE). The materials were characterized by scanning electron microscopy (SEM) and X-ray diffraction (XRD). The sensor performance under different solution conditions was systematically evaluated by electrochemical methods. Furthermore, the stability and repeatability were assessed. Results: A nanocomposite with a distinct layered structure was successfully prepared. In the neutral aqueous solution, the sensor demonstrated excellent electrochemical responses to As (Ⅲ). A good linear relationship was observed between the response signal and As (Ⅲ) concentration within the range of 100-500 μg · mL-1. The sensor showed good stability and repeatability. Moreover, it performed well in the determination of As (Ⅲ) in Realgar samples. Conclusion: The electrochemical sensor enables rapid and accurate determination of As (Ⅲ) in Realgar under neutral conditions, with simple operation and high sensitivity. It offers a new method for quality control of Realgar-containing Chinese medicine preparations.
  • Standard Deliberation
    GUO Bin, ZHANG Shan-shan, ZHANG Mei-ling, HUANG Bing-bing, CHEN Rong, ZHANG Hua-feng
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1551-1559. https://doi.org/10.16155/j.0254-1793.2025-0593
    Objective: To establish a method for determining the particle size and particle size distribution of dapagliflozin based on laser diffraction. Methods: The Malvern Mastersizer 3000 laser size analyzer with the Malvern SV sample dispersion unit was used to determine the particle size and particle size distribution of dapagliflozin by the wet method. The Isopar G containing 2% of Span 80 was used for pre-dispersion. The dapagliflozin samples had the refractive index of 1.614 and the absorbance of 0.01. The Isopar G was used for dispersion, with laser obscurations of 8%-15%. The samples were determined after sonicating for 60 s at the pump speed of 2 500 r · min-1. Results: The particle size and particle size distribution of dapagliflozin products could be analyzed accurately by the laser diffraction wet method. The D[4,3] could show the size differences between different products. The RSDs of methodological survey for d(0.1), d(0.5), and d(0.9) were lower than 5%, which indicated good repeatability. The particle size distribution d(0.9) values of 12 batches of dapagliflozin were less than the standard limit (30 μm) in quality control. Conclusion: The method is accurate and repeatable, and suitable for the particle size determination of dapagliflozin. Moreover, it provides reference for the development of particle size determination methods for other drugs prone to agglomeration and moisture absorption.
  • Ingredient Analysis
    ZHOU Guo-liang, YU Hao, CHEN Hao, WANG Yu, SHANG Er-xin, SU Shu-lan, DUAN Jin-ao
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1190-1201. https://doi.org/10.16155/j.0254-1793.2025-0661
    Objective: To establish an ultra-performance liquid chromatography-triple quadrupole-mass spectrometry (UPLC-TQ/MS) method for the simultaneous determination of 13 chemical components in Tripterygii Wilfordii Radix (TP) and Pteris Multifidae Herba (PM) and to quantitatively analyze the dissolution changes of chemical components in TP-PM combinations with different ratios. From the perspective of chemical components, this study analyzes the dissolution changes of chemical components in TP-PM combinations with different ratios to determine the optimal compatibility ratio, aiming to provide a basis for elucidating the dose-effect relationship and guiding clinical medication. Methods: Chemical components in TP-PM combinations with different ratios (1 ∶ 4, 1 ∶ 2, 1 ∶ 1, 2 ∶ 1, and 4 ∶ 1) were extracted with water and 70% ethanol, respectively. The dissolution rates of 13 chemical components across the different compatibility ratio groups were analyzed by the UPLC-TQ/MS method. An AcquityTM UPLC BEH C18 chromatographic column (2.1 mm×50 mm, 1.7 μm) was used for gradient elution with the mobile phase consisting of acetonitrile and 0.1% formic acid aqueous solution at a flow rate of 0.3 mL · min-1. Detection was performed through electrospray ionization (ESI+) in positive and negative ion modes (ESI-) with multiple reaction monitoring (MRM). Results: After extraction with 70% ethanol, the total dissolution rates of six terpenoids in the TP-PM combinations with different ratios were all lower than that in TP alone 70% ethanol extract (group C0) (P<0.05). The total dissolution rates of six terpenoids in the water extracts of TP-PM combinations were lower than those in the 70% ethanol extracts. In particular, the dissolution rate of six terpenoids in the TP-PM (1 ∶ 2) water extract group (group S2) was the lowest. Whether water extraction or 70% ethanol extraction, the dissolution rates of all TP-PM combination groups were higher than those of the TP water extract (group S0) and group C0 (P<0.01). Compatibility promoted the dissolution of wilforine, and the dissolution rate was the highest in the group S2. The total dissolution rates of six flavonoids in the TP-PM combinations extracted with 70% ethanol were lower than that of the 70% ethanol extract of PM (group FC0) (P<0.05). The total dissolution rates of six flavonoids in the TP-PM combinations extracted with water were higher than those extracted with 70% ethanol and higher than that in the PM water extract (group FS0) (P<0.01). The total dissolution rate of six flavonoids was the highest in the group S2. Conclusion: Both water extraction and 70% ethanol extraction significantly affect the dissolution rates of six terpenoids, wilforine, and six flavonoids in the TP-PM combinations with different ratios, with TP-PM (1 ∶ 2) water extraction being the most effective. The findings provide a scientific basis for the safe clinical use of the drugs.
  • Safety Monitoring
    YANG Hong-xia, LIAO Hui, ZHANG Lu, WANG Zhi-jian, LI Jue, ZHENG Xiao-ling, ZHANG Lin-shuang, CAO Jie
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1330-1336. https://doi.org/10.16155/j.0254-1793.2025-0623
    Objective: To establish a rapid coculture and detection method for six pathogenic bacteria (Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Salmonella paratyphi B, Pseudomonas aeruginosa, and Burkholderia cepacia) in cosmetics and raw materials based on the gene membrane chip technology and improve the biological safety assurance capability and risk screening efficiency of the product. Methods: The co-culture medium was used for co-culture of the six pathogenic bacteria, and specific primers and probes for the six pathogenic bacteria were designed. Multiplex PCR amplification was performed on the sample nucleic acid, and the gene membrane chip technology was employed for further product hybridization and analysis. Results: Specificity tests showed that the six pathogenic bacteria developed color only at their corresponding target spots, while the four negative template bacteria (Listeria monocytogenes, Bacillus cereus, Vibrio vulnificus, and Shigella spp.) showed no color development, indicating no cross-reaction and good probe specificity. At primer concentrations of 0.20/0.30 μmol · L-1 (internal control) and 0.067-0.75 μmol · L-1 (for the six targets), the color development intensities of all targets were uniform. The limit of detection (LOD) test showed that the established method achieved an LOD of 1.0×105 copies · mL-1 for all six pathogenic bacteria. The test results of nine batches of samples were all negative, consistent with those obtained by conventional methods. The established method specifically detected the corresponding targets in the spiked samples without cross-interference, meeting the requirements for routine testing. Conclusion: A co-culture method for six pathogenic bacteria in cosmetics and a multiplex detection method based on PCR-gene membrane chip technology were established. This method exhibits strong specificity, good stability, and high sensitivity, ensuring the quality and safety of cosmetics and raw materials. It can be further applied to the detection of cosmetics in factories and markets, enriching the detection methods for pathogenic bacteria in the cosmetics industry and providing a rapid and powerful technical means for detection.
  • Metabolism Analysis & Activity Analysis
    CAO Hai-yang, SHAN Bai-xi, ZHAO Peng, DU Yan, LIU Xin-guang, ZHANG Qin, JIANG Yu-hang, ZHANG Zhi-jing, LI Jian-sheng
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1225-1245. https://doi.org/10.16155/j.0254-1793.2025-0405
    Objective: To qualitatively analyze the chemical components of Zaoshi Huatan Xiefei formula, as well as the components absorbed into the blood and lung based on ultra-high performance liquid chromatography coupled with Quadrupole/Electrostatic field Orbitrap high-resolution mass spectrometry (UPLC-Q Exactive Orbitrap MS/MS). Methods: Chromatographic separation was performed on a Phenomenex Synergi™ Polar-RP column (2 mm×150 mm, 4 μm) with a mobile phase consisting of 0.1% aqueous formic acid (A) and 0.1% formic acid in acetonitrile (B). Gradient elution (0-1 min, 0%B; 1-40 min, 0%B→85%B; 40-43 min, 85%B→100%B; 43-44 min, 100%B→0%B; 44-45 min, 0%B) was conducted with the flow rate of 0.3 mL · min-1, the column temperature maintained at 40 ℃, and the injection volume of 5 µL. An electrospray ionization (ESI) source in both positive and negative ion full-scan mode was used for data acquisition, with a scanning range of m/z 114-1 700 and collision energy of 20, 40, and 60 eV. Chemical components of Zaoshi Huatan Xiefei formula and the components absorbed into the blood and lung were identified by comparing retention time, accurate relative molecular mass, MS/MS fragment ions, reference standards, and relevant literature data. Results: A total of 192 compounds were identified or tentatively characterized in Zaoshi Huatan Xiefei formula, including 41 flavonoids, 45 organic acids, 9 alkaloids, 13 amino acids, 19 phenylpropanoids, 17 terpenoids, 11 saponins, and 37 compounds belonging to other categories. Seventeen compounds were confirmed by comparison with reference standards. Sixty-six prototype components were detected in plasma, and twenty-four were detected in lung tissue. Additionally, the fragmentation pathways of naringin, chlorogenic acid, trigonelline, cryptotanshinone, and magnolol were analyzed. Conclusion: This study comprehensively and rapidly characterizes the diverse chemical components of Zaoshi Huatan Xiefei formula and identifies the components absorbed into the blood and lung. The findings provide a basis for understanding the pharmacological material basis of Zaoshi Huatan Xiefei formula, supporting its clinical application and facilitating new drug development.
  • Bioassay
    DONG Guo-xia, SHI Bo-zhi, TAN Ya-jun, XUE Yan-hua, TIAN Lin, SHI Ji-chun, YUAN Li-yong
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(7): 1307-1311. https://doi.org/10.16155/j.0254-1793.2025-0698
    Objective: To optimize and validate the specific neutralization test method for the Corynebacterium diphtheriae strain C7 (β197) (strain C7), thereby improving the clarity of results and shortening the detection time. Methods: Strain C7 was inoculated in both wide and narrow patterns. A filter paper strip was placed either on the surface of culture medium or embedded within the culture medium. Seven types of culture media—peptone A Elek’s medium, peptone B Elek’s medium, peptone C Elek’s medium, peptone D Elek’s medium, peptone E Elek’s medium, nutrient agar medium, and commercially available Elek’s medium—were screened. Diphtheria antitoxin was prepared at four concentrations: 2 000, 1 500, 1 000, and 500 Lf · mL-1. Petri dishes were poured with 15, 25, and 35 mL of culture medium, and strain C7 was inoculated at distances of 3, 5, 7, 9, and 11 mm from the filter paper strip. Equine serum or bovine serum was added to the basal culture medium. The key conditions for the specific neutralization test of strain C7 were systematically optimized and screened. Additionally, the specificity and repeatability of the optimized method were validated. Results: The optimal conditions for the specific neutralization test were determined as follows: strain C7 inoculated in a narrow pattern, filter paper strip placed on the surface of culture medium, peptone C Elek’s medium used as the neutralization medium, filter paper strip saturated with diphtheria antitoxin at 1 500 Lf · mL-1, petri dish poured with 15 mL medium, strain C7 inoculated at a distance of 3 mm from the filter paper strip, and bovine serum added to the basal medium. The validation results demonstrated that the optimized method had good specificity and repeatability. Conclusion: The specific neutralization test method optimized in this study is stable and reliable. It significantly improves the clarity of results and detection efficiency for strain C7, providing more efficient and reliable technical support for the laboratory identification of this bacterium and the quality control of related vaccines.
  • Activity Analysis
    CHEN Si-yu, XU Yang, CHEN Sheng-nan, ZHANG Ya-jie, BAO Hui-wei
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1459-1471. https://doi.org/10.16155/j.0254-1793.2026-0022
    Objective: This study aimed to establish a high-speed countercurrent chromatography (HSCCC) method for the separation of catechin (CAT) and epicatechin (EC) from Catechu, and to investigate the effects of CAT and EC on skin pruritus and vascular permeability in mice. Methods: High-purity CAT and EC were successfully isolated from Catechu by HSCCC with optimized separation parameters. An Agilent TC-C18 column (250 mm×4.6 mm, 5 μm) was adopted for high-performance liquid chromatography analysis. Methanol-water (30 ∶ 70) served as the mobile phase under isocratic elution conditions, with a flow rate of 1.0 mL · min-1, injection volume of 10 μL, column temperature of 30 ℃, and detection wavelength set at 280 nm. Pruritus mouse models induced by histamine (HA), chloroquine (CQ) and 2,4-dinitrofluorobenzene (DNFB) were established to evaluate the antipruritic efficacy of CAT and EC as well as their influences on cutaneous vascular permeability. Results: The purity of CAT and EC separated by HSCCC was 95.2% and 96.4%, with recovery rates of 83.4% and 84.1%, respectively. In mouse models of acute and chronic pruritus, the low-dose CAT group (CAT-L, 200 mg · kg-1), high-dose CAT group (CAT-H, 400 mg · kg-1), low-dose EC group (EC-L, 50 mg · kg-1), and high-dose EC group (EC-H, 100 mg · kg-1) all significantly reduced the frequency of scratching, decreased skin vascular permeability, and inhibited the release of inflammatory factors in a clear dose-dependent manner. The high-dose groups exhibited significantly better effects on antipruritus and improving vascular permeability than the low-dose groups. Conclusion: This study is the first to establish and optimize an HSCCC system for the separation of CAT and EC from Catechu, and the first to systematically evaluate their antipruritic activities and characteristics in acute and chronic pruritus models. The method is efficient, stable, simple, and yields high-purity products, making it suitable for the separation and preparation of CAT and EC from Catechu. Both CAT and EC show significant therapeutic effects on acute and chronic pruritus, providing new directions and experimental references for the research and development of natural drugs against skin pruritus.
  • Metabolism Analysis
    GAN Zhen, LI Jin-fa, WANG Yu, CHEN Si-yuan, CHANG Jun-min
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1449-1458. https://doi.org/10.16155/j.0254-1793.2026-0069
    Objective: To establish and validate an ultra-performance liquid chromatography-tandem mass spectrometry method, and to systematically investigate the pharmacokinetics, tissue distribution, and excretion of Melezitose in rats. Methods: Biological samples were prepared by protein precipitation with acetonitrile, and 2’-fucosyllactose was used as the internal standard. Quantitative analysis was performed by UPLC-MS/MS in the negative ESI mode with multiple reaction monitoring (MRM). Chromatographic separation was performed on a Waters Acquity UPLC BEH Amide column (2.1 mm×150 mm, 1.7 μm), using 0.1% ammonia aqueous solution (A) and acetonitrile (B) as the mobile phase with gradient elution (0-5 min, 85%B→75%B; 5-10 min, 75%B→65%B; 10-15 min, 65%B→70%B). The flow rate was 0.25 mL · min-1, the column temperature was 40 ℃, and the injection volume was 10 μL. Mass spectrometric detection was carried out on a Waters TQD triple quadrupole with an ESI source in negative ion mode, using MRM for quantification. The capillary voltage was 2.8 kV, the cone voltage was 30 V, the source temperature was 120 ℃, the desolvation temperature was 450 ℃, the nitrogen flow rate was 800 L · h-1, and argon was used as the collision gas. The method was validated for specificity, linearity, accuracy, precision, recovery, matrix effect, stability, and dilution integrity. Based on the validated method, three intragastric administration groups of melezitose (200 mg · kg-1, 400 mg · kg-1, 800 mg · kg-1) and intravenous administration group (200 mg · kg-1) were established to investigate its pharmacokinetics, tissue distribution, as well as urinary and fecal excretion characteristics in rats. Results: Melezitose exhibited good linearity over the concentration range of 0.1-20 μg · mL-1, with a lower limit of quantification of 0.1 μg · mL-1. All validation parameters met the requirements for quantitative analysis of biological samples. The absolute oral bioavailability of melezitose after intragastric administration ranged from 6.70% to 7.34%. The tissue distribution results demonstrated that the highest exposure level of melezitose occurred in the small intestine, followed by a rapid decline. The excretion study revealed that approximately 60% of intragastrically administered melezitose was excreted as the parent compound in feces within 36 h, while the urinary excretion accounted for less than 3% of the dose. Conclusion: The established UPLC-MS/MS method is sensitive, accurate, and robust, and is suitable for the systematic quantification of melezitose in rats.
  • Ingredient Analysis
    LÜ Feng-jiao, LIU Min, WEN Yun, XIE Xiao-lan
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1404-1411. https://doi.org/10.16155/j.0254-1793.2025-0361
    Objective: To establish a high-performance liquid chromatography (HPLC) method for the determination of diosmetin in thermosensitive liposomes and investigate its in vitro release behavior. Methods: HPLC was conducted with a Supersil ODS2 column (250 mm×4.6 mm, 5 μm), the detection wavelength of 343 nm, and the injection volume of 20 μL. Single-factor experiments were carried out to investigate the influences of mobile phase methanol-water ratio by volume, flow rate, and column temperature and optimize the chromatographic conditions. With 1% Tween 80 aqueous solution as the release medium, the in vitro release behavior of diosmetin-loaded thermosensitive liposomes at different temperatures was investigated via dialysis coupled with constant-temperature shaking. The cumulative release rate was calculated, and Origin software was adopted to fit drug release models. Results: The optimized chromatographic conditions were as follows: a mobile phase composed of methanol and water at a volume ratio of 75 ∶ 25, a flow rate of 1 mL · min-1, and a column temperature of 35 ℃. Diosmetin exhibited a good linear relationship between peak area and concentration within the range of 0.1-50 μg · mL-1, and the regression equation was A=86.489C-2.142 2 (r=1.000). The limit of detection was 0.6 ng, and the limit of quantitation was 1.8 ng. The spiked recoveries at high, medium, and low concentrations were all above 95%, and the RSD values were all less than 2%. In vitro release experiments revealed that diosmetin-loaded thermosensitive liposomes exhibited obvious temperature responsiveness. Compared with free diosmetin, the liposomes showed slow drug release at 37 ℃, whereas the release rate rose significantly at 42 ℃ and 53 ℃. The release behavior at 37, 42, and 53 ℃ all complied with the first-order kinetic model. Conclusion: This method is simple, stable, and efficient, and is thus suitable for the in vitro release evaluation of diosmetin-loaded thermosensitive liposomes. Furthermore, the prepared liposomes exhibit heat-triggered drug release behavior and sustained-release properties, and their release behavior is primarily dominated by diffusion.
  • Ingredient Analysis
    HUANG Yan-chang, HUANG Yu-tong, XUE He-fei, XING Yan-ping, YANG Yan-yun, KANG Ting-guo, DOU De-qiang, XU Liang
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1420-1430. https://doi.org/10.16155/j.0254-1793.2025-0462
    Objective: To investigate the histological structural differences and the spatial distribution characteristics of saponins in the roots and rhizomes of Pulsatilla chinensis (Bunge) Regel, Pulsatilla cernua (Thunb.) Bercht. & J. Presl, and Pulsatilla turczaninovii Krylov & Serg. by combining microscopy and matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI). Methods: The histological structural characteristics of the roots and rhizomes of three Pulsatilla species were observed and compared by microscopy. An OLYMPUS microscopic imaging system and a BX-51 biological microscope equipped with a DP-72 microscope digital camera and polarizing filters were used for observation, and the microscopic features were documented. For MALDI-MSI analysis, tissue sections were prepared through a Leica CM1950 cryostat, and DHB matrix was applied with a TM-Sprayer matrix sprayer. The matrix-coated ITO slides were placed on the mass spectrometer target plate, and tissue regions of interest were selected by DataImaging. Under identical laser energy, the TimsTOF fleX mass spectrometry system was used to identify and detect tissue samples, and the in situ spatial distribution of 21 saponins, including the marker component pulchinenoside B4 specified in the Pharmacopoeia of the People’s Republic of China, was visualized across different tissue regions of the roots and rhizomes. Results: Microscopic observations revealed that the roots of all the three species possessed a distinct endodermis (with prominent casparian strips), while the rhizomes contained a pith or fissures. Significant interspecies differences were observed in the number of xylem bundles and the distribution of phloem fibers. MALDI-MSI results revealed that among the 21 saponins, the majority (17) of saponins were predominantly enriched in the cortical tissue, while 4 were undetected. Some saponins (pulchinenoside D and pulchinenoside E2) exhibited a unique ring-shaped distribution pattern in the endodermal region of the roots or rhizomes, most prominently in the roots of P. chinensis and P. cernua. Pulchinenoside E showed higher distribution in the xylem. Conclusion: This study reveals the specific spatial distribution patterns of saponins (cortex enrichment and endodermal ring distribution) in the roots and rhizomes of these three Pulsatilla species and clarifies the interspecies differences in their microscopic tissue structures. This study reveals histochemical differences among three Pulsatilla species and between their roots and rhizomes, providing a histochemical basis for species identification and the scientific evaluation and development of medicinal resources of this genus.
  • Safety Monitoring
    ZHANG Lei, FENG Yan-chun, DUAN Shu-tao, ZHU Shi-jie
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1498-1504. https://doi.org/10.16155/j.0254-1793.2025-0653
    Objective: To establish a high performance liquid chromatography (HPLC) method for the determination of enantiomer in dapagliflozin. Methods: The determination was performed through a CAPCELL PAK MG Ⅱ C18 column (250 mm×4.6 mm, 3.0 µm) at the column temperature of 30 ℃, with the mobile phase consisting of acetonitrile and water at a ratio of 43 ∶ 57 at the flow rate of 0.7 mL · min-1. The detection wavelength was set at 225 nm, and the injection volume at 10 μL. Results: The peaks of dapagliflozin and enantiomer were well separated. The calibration curve of enantiomer was linear in the range of 0.051 8-10.36 μg · mL-1 (r=0.999 9). The limit of quantification was 0.05 μg · mL-1, and the limit of detection was 0.02 μg · mL-1. The average recovery of enantiomer was 98.8%, with the RSD of 2.1%. The test results of three batches of dapagliflozin samples showed that the content of enantiomer and other unknown impurities was 0.6 mg · g-1 and 0.1 mg · g-1, respectively, and the total amount of impurities was less than 1.0 mg · g-1. Conclusion: The established method is accurate and reliable. It can be used for the quality control of dapagliflozin.
  • Safety Monitoring
    GUO Ri-xin, XIE Si-min, XIAO Meng, DAI Zhong, LIU Jing, WEI Feng, LIN Yong-qiang
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1505-1514. https://doi.org/10.16155/j.0254-1793.2025-0621
    Objective: To determine the content of eight aristolochic acid components in Liujing Toutong tablets, thus providing reference for the quality control. Methods: An ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was established to determine the content of aristolochic acidⅠ, aristolochic acid Ⅱ, aristolochic acid Ⅳa, aristolochic acid Ⅶa, aristolactamⅠ, aristolactam AⅡ, aristolactam BⅡ, and aristolactam FⅠ in Liujing Toutong tablets. Gradient elution was carried out through an Agilent ZOBARX SB C18 column (50 mm×2.1 mm, 1.8 μm), with methanol as mobile phase A and 0.1% formic acid solution (containing 1 mmol · L-1 ammonium acetate) as mobile phase B. The electrospray ionization (ESI) in positive ion multi-reaction monitoring mode was adopted. The content of the eight aristolochic acid components in Liujing Toutong tablets was calculated with the standard curve method. Results: Aristolochic acid Ⅱ and aristolactam BⅡ were detected in none of the samples. The content of aristolochic acid Ⅰ, aristolochic acid Ⅳa, and aristolactam Ⅰ varied within the ranges of 0.010-0.055 μg · g-1, 0.064-0.998 μg · g-1, and 0.028-0.454 μg · g-1, respectively. Aristolochic acid Ⅶa, aristolactam FⅠ, and aristolactam AⅡ were detected in some samples but all below the limits of quantitation. Conclusion: The UPLC-MS/MS method is established for determining the content of eight aristolochic acid components in Liujing Toutong tablets, with high specificity, high sensitivity, good repeatability, which can provide reference for the quality control and safety supervision of Liujing Toutong tablets.
  • Ingredient Analysis
    AILI Re-ze-ye, HONG Yu-wen, GU Yue, TAO Chu-jun, QIU Feng
    Chinese Journal of Pharmaceutical Analysis. 2026, 46(8): 1390-1403. https://doi.org/10.16155/j.0254-1793.2025-0665
    Objective: To predict the potential quality markers (Q-markers) of Tongluo Mingmu capsules based on network pharmacology and establish an ultra-high performance liquid chromatography-ultraviolet detection (UPLC-UV) method for their simultaneous quantification, thus improving the quality standard of Tongluo Mingmu capsules. Methods: The “component-target-metabolic pathway” interaction data of Tongluo Mingmu capsules were collected through network pharmacology approaches, and the resulting network was constructed for visualization. UPLC-UV was performed through an Acquity UPLC HSS T3 column (100 mm×2.1 mm, 1.8 μm) with a column temperature of 30 ℃. The mobile phase consisted of 0.1% formic acid aqueous solution (A)-acetonitrile (B) for gradient elution with the flow rate of 0.30 mL · min-1 at the detection wavelength of 261 nm. The injection volume was set to be 5 μL. The UPLC-UV method was then used to simultaneously quantify 14 components (puerarin, paeoniflorin, luteolin, formononetin, aloeemodin, physcion, rhein, emodin, chrysophanol, ecliptasaponin A, specnuezhenide, ginsenoside Rg1, daidzein, and wedelolactone) in Tongluo Mingmu capsules. Results: A total of 35 potential Q-markers of Tongluo Mingmu capsules were screened out, which could bind to protein targets such as TP53 to regulate signaling pathways including the PI3K-Akt signaling pathway. All method validation indexes of the established UPLC-UV method met the methodological requirements. In three batches of Tongluo Mingmu capsule samples, the content ranges of puerarin, paeoniflorin, luteolin, formononetin, aloe-emodin, physcion, rhein, emodin, chrysophanol, ecliptasaponin A, specnuezhenide, ginsenoside Rg1, daidzein, and wedelolactone were 0.350-0.376 mg per capsule, 2.198-2.666 mg per capsule, 0.187-0.249 mg per capsule, 0.040-0.046 mg per capsule, 0.078-0.086 mg per capsule, 0.214-0.272 mg per capsule, 0.142-0.152 mg per capsule, 0.148-0.162 mg per capsule, 0.288-0.321 mg per capsule, 0.409-0.491 mg per capsule, 2.630-3.220 mg per capsule, 0.021-0.028 mg per capsule, 0.019-0.026 mg per capsule, and 2.108-2.566 mg per capsule, respectively. Conclusion: Network pharmacology provides a theoretical basis for the screening of Q-markers in Tongluo Mingmu capsules. The established UPLC-UV method can be used to improve the quality standard of Tongluo Mingmu capsules.